Weekly Communique #12
2 July, 2020
WEEK IN REVIEW Taskforce makes first recommendation on Dexamethasone The Taskforce has made two conditional recommendations on the use of dexamethasone in treatment of patients with COVID-19: Consider using dexamethasone 6 mg daily intravenous or oral for up to 10 days in adults with COVID-19 who are receiving oxygen (including mechanically ventilated patients). * Do not routinely use dexamethasone to treat COVID-19 in adults...